The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth

Document Details

Document Type: Pub Defense Publication
Publication Date: Jan 17, 2022
Source ID: 10.1007/s10549-021-06487-y

Entities

People

Cynthia Besch-williford
Salman M. Hyder
Yayun Liang

Organizations

United States Department of Defense